One-Piece Intraocular Lenses 의 안전성 경고

Department of Health에 따르면, 해당 안전성 경고 는 Hong Kong 에서 Hoya Corporation 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

안전성 경고는 의료기기 제품과 관련된 중요한 정보와 권고사항을 담고 있습니다. 물론 안전성 경고가 배포되었다고 해서 해당 제품이 무조건 안전하지 않은 제품이라는 것은 아닙니다. 보건의료업계 종사자와 의료기기 사용자들에게 배포되는 안전성 경고에는 회수(recall)도 포함될 수 있습니다. 제조사가 안전성 경고를 작성하기도 하지만, 보건당국에서 작성하는 경우도 있습니다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Safety alert
  • 날짜
    2013-02-22
  • 사례 출판 날짜
    2013-02-22
  • 사례 국가
  • 사례 출처
    DH
  • 사례 출처 URL
  • 비고 / 경고
    Hong Kong data is current through September 2018. All of the data comes from the Department of Health (Hong Kong), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Hong Kong.
  • 데이터 추가 비고
    Medical Device Safety Alert
  • 원인
    Medical device safety alert: hoya one-piece intraocular lenses medical device manufacturer, hoya corporation issued a medical device safety alert concerning hoya one-piece intraocular lenses (iol). the affected models are: ny-60 (hoya af-1 imics1) 311 (hoya af-1 toric) 250 and 251 (hoya isert) 351 (hoya isert toric) last month, hoya surgical optics announced a voluntary suspension of shipment of five of their products while they investigated reports of higher than expected rates of inflammation and/or endophthalmitis from doctors using ny-60, isert 250, and isert 251 iols in a few countries. an extensive review of manufacturing process revealed that some products had trace residual foreign particulates on them. the manufacturer has been unable to definitively determine if they were linked to the adverse events but the potential may exist. although no adverse events have been reported with the toric lenses, they were included in the recall because they follow a similar manufacturing process. the manufacturer clarified that no other hoya iols, in particular no three-piece iols, are affected by this recall. according to the manufacturer, this issue may lead to post-operative inflammation and/or endophthalmitis. however, there is no evidence, and no reports of any new cases of inflammation and or endophthalmitis associated with the iols that have been implanted for six months or longer. product recall is ongoing. furthermore, for any patient already implanted with one of the lenses included in this recall, hoya recommends following the patient for three to six months post-operatively to monitor for the possible onset of ocular inflammation. according to the local supplier, hong kong medical supplies ltd., the affected products have been distributed in hong kong. if you are in possession of the affected products, please contact your supplier for necessary actions. posted on 22 february 2013.

Device

  • 모델명 / 제조번호(시리얼번호)
  • 제품 설명
    Medical Device Safety Alert: HOYA One-Piece Intraocular Lenses
  • Manufacturer

Manufacturer